Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
Advanced Wound Care Market Growth & Trends
The global advanced wound care market size is expected t%li%reach USD 14.87 billion by 2030, expanding at a CAGR of 4.79% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. Growth in the number of the aging population as well as an increasing figure of diabetic patients are some major factors driving this market’s growth.
For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021, increasing the number of senior populations is anticipated t%li%propel the market during the forecast period.
There has been growth in the number of surgical procedures, and traumatic incidents globally. For instance, as per a study by Research Gate, in 2022, around 6.6% of mortality occurs due t%li%trauma every year. Similarly, there has been an increase in the number of surgical site infections. Advanced wound care products help t%li%contain and reduce these surgical site infections, thereby, an increase in the number of surgical site infections is expected t%li%drive the market during the forecast period.
The introduction of the COVID-19 vaccine, and the lifting of lockdown impositions, are expected t%li%have a positive impact on the market over the forecast period. Many elective surgeries, which were postponed, are expected t%li%take place. In addition t%li%this, many leading manufacturers are introducing new products which may help them t%li%capitalize on the increasing demand for advanced wound care products during the forecast period.
Advanced Wound Care Market Report Highlights
Advanced Wound Care Market Growth & Trends
The global advanced wound care market size is expected t%li%reach USD 14.87 billion by 2030, expanding at a CAGR of 4.79% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. Growth in the number of the aging population as well as an increasing figure of diabetic patients are some major factors driving this market’s growth.
For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021, increasing the number of senior populations is anticipated t%li%propel the market during the forecast period.
There has been growth in the number of surgical procedures, and traumatic incidents globally. For instance, as per a study by Research Gate, in 2022, around 6.6% of mortality occurs due t%li%trauma every year. Similarly, there has been an increase in the number of surgical site infections. Advanced wound care products help t%li%contain and reduce these surgical site infections, thereby, an increase in the number of surgical site infections is expected t%li%drive the market during the forecast period.
The introduction of the COVID-19 vaccine, and the lifting of lockdown impositions, are expected t%li%have a positive impact on the market over the forecast period. Many elective surgeries, which were postponed, are expected t%li%take place. In addition t%li%this, many leading manufacturers are introducing new products which may help them t%li%capitalize on the increasing demand for advanced wound care products during the forecast period.
Advanced Wound Care Market Report Highlights
- Based on product, the moist wound care segment led the market with the largest revenue share of 70.75% in 2024. This dominance can be attributed t%li%an increase in a number of wound cases and increase in number of surgeries globally.
- In terms of application, the chronic wounds segment is dominating the market with the largest revenue share in 2024. Increasing number of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds is expected t%li%drive the segment growth.
- Based on end-use, the hospital segment held the market with the largest revenue share of 45.37% in 2024. The growth of this segment can be attributed t%li%the upsurge in surgical procedures and increase in the number of hospital admissions.
- North America dominated the market with the revenue share of 45.47% in 2024. This dominance can be attributed t%li%well-developed healthcare infrastructure and increase in the number of surgical procedures.
- Asia Pacific is anticipated t%li%witness fastest CAGR during the forecast period. This can be attributed t%li%the presence of major key players, the increasing prevalence of chronic disorders, and rising healthcare expenditure.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Application Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective
1.10.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. ADVANCED WOUND CARE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.2.1.2. Introduction of innovative and advanced wound products
3.2.1.3. Rising geriatric population
3.2.1.4. Increasing number of road accidents, trauma cases, and burns
3.2.1.5. Increasing number of surgeries
3.2.2. Market restraint analysis
3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
3.3. Advanced Wound Care Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
CHAPTER 4. ADVANCED WOUND CARE MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Advanced Wound Care Market Product Movement Analysis
4.3. Global Advanced Wound Care Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Moist
4.4.1. Moist market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Foam Dressings
4.4.2.1. Foam dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Hydrocolloid Dressings
4.4.3.1. Hydrocolloid dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Film Dressings
4.4.4.1. Film dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Alginate Dressings
4.4.5.1. Alginate dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Hydrogel Dressings
4.4.6.1. Hydrogel dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Collagen Dressings
4.4.7.1. Hydrocolloid dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Other Advanced Dressings
4.4.8.1. Other advanced dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Antimicrobial
4.5.1. Antimicrobial market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Silver
4.5.2.1. Silver market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Non-silver
4.5.3.1. Non-silver market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Active
4.6.1. Active market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Biomaterials
4.6.2.1. Biomaterials market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Skin-substitute
4.6.3.1. Skin-substitute market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Growth Factors
4.6.4.1. Growth factors market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. ADVANCED WOUND CARE MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Advanced Wound Care Market Application Movement Analysis
5.3. Global Advanced Wound Care Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Chronic Wounds
5.4.1. Chronic wounds market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Diabetic Foot Ulcers
5.4.2.1. Diabetic foot ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Pressure Ulcers
5.4.3.1. Pressure ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Venous Leg Ulcers
5.4.4.1. Venous leg ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Other Chronic Wounds
5.4.5.1. Other chronic wounds market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Acute Wounds
5.5.1. Acute wounds market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Surgical & Traumatic Wounds
5.5.2.1. Surgical & traumatic wounds market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. Burns
5.5.3.1. Burns market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. ADVANCED WOUND CARE MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Advanced Wound Care Market End Use Movement Analysis
6.3. Global Advanced Wound Care Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Specialty Clinics
6.5.1. Specialty Clinics market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Home Healthcare
6.6.1. Home healthcare market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. ADVANCED WOUND CARE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT, APPLICATION, AND END USE
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Competitive scenario
7.4.1.3. Regulatory framework
7.4.1.4. Reimbursement scenario
7.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. Reimbursement scenario
7.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. Reimbursement scenario
7.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement scenario
7.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement scenario
7.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement scenario
7.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. Reimbursement scenario
7.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory framework
7.5.6.4. Reimbursement scenario
7.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Reimbursement scenario
7.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Regulatory framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement scenario
7.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement scenario
7.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement scenario
7.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement scenario
7.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement scenario
7.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. ConvaTec Group PLC
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Smith & Nephew PLC
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Mцlnlycke Health Care AB
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. B. Braun Melsungen AG
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. 3M
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. URGO
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Coloplast Corp.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Integra LifeSciences
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Medline Industries, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Application Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective
1.10.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. ADVANCED WOUND CARE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.2.1.2. Introduction of innovative and advanced wound products
3.2.1.3. Rising geriatric population
3.2.1.4. Increasing number of road accidents, trauma cases, and burns
3.2.1.5. Increasing number of surgeries
3.2.2. Market restraint analysis
3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
3.3. Advanced Wound Care Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
CHAPTER 4. ADVANCED WOUND CARE MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Advanced Wound Care Market Product Movement Analysis
4.3. Global Advanced Wound Care Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Moist
4.4.1. Moist market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Foam Dressings
4.4.2.1. Foam dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Hydrocolloid Dressings
4.4.3.1. Hydrocolloid dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Film Dressings
4.4.4.1. Film dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Alginate Dressings
4.4.5.1. Alginate dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Hydrogel Dressings
4.4.6.1. Hydrogel dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Collagen Dressings
4.4.7.1. Hydrocolloid dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Other Advanced Dressings
4.4.8.1. Other advanced dressings market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Antimicrobial
4.5.1. Antimicrobial market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Silver
4.5.2.1. Silver market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Non-silver
4.5.3.1. Non-silver market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Active
4.6.1. Active market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Biomaterials
4.6.2.1. Biomaterials market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Skin-substitute
4.6.3.1. Skin-substitute market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Growth Factors
4.6.4.1. Growth factors market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. ADVANCED WOUND CARE MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Advanced Wound Care Market Application Movement Analysis
5.3. Global Advanced Wound Care Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Chronic Wounds
5.4.1. Chronic wounds market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Diabetic Foot Ulcers
5.4.2.1. Diabetic foot ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Pressure Ulcers
5.4.3.1. Pressure ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Venous Leg Ulcers
5.4.4.1. Venous leg ulcers market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Other Chronic Wounds
5.4.5.1. Other chronic wounds market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Acute Wounds
5.5.1. Acute wounds market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Surgical & Traumatic Wounds
5.5.2.1. Surgical & traumatic wounds market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. Burns
5.5.3.1. Burns market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. ADVANCED WOUND CARE MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Advanced Wound Care Market End Use Movement Analysis
6.3. Global Advanced Wound Care Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Specialty Clinics
6.5.1. Specialty Clinics market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Home Healthcare
6.6.1. Home healthcare market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. ADVANCED WOUND CARE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT, APPLICATION, AND END USE
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Competitive scenario
7.4.1.3. Regulatory framework
7.4.1.4. Reimbursement scenario
7.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Regulatory framework
7.4.2.4. Reimbursement scenario
7.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Regulatory framework
7.4.3.4. Reimbursement scenario
7.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement scenario
7.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement scenario
7.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement scenario
7.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Regulatory framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Regulatory framework
7.5.5.4. Reimbursement scenario
7.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Regulatory framework
7.5.6.4. Reimbursement scenario
7.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Regulatory framework
7.5.7.4. Reimbursement scenario
7.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Regulatory framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement scenario
7.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement scenario
7.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement scenario
7.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement scenario
7.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement scenario
7.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement scenario
7.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement scenario
7.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework
7.8.3.4. Reimbursement scenario
7.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Regulatory framework
7.8.4.4. Reimbursement scenario
7.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. ConvaTec Group PLC
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Smith & Nephew PLC
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Mцlnlycke Health Care AB
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. B. Braun Melsungen AG
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. 3M
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. URGO
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Coloplast Corp.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Integra LifeSciences
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Medline Industries, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
